Literature DB >> 23011953

Clinical significance of infections caused by plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamase-producing Escherichia coli.

H S Cheong1, K S Ko, C-I Kang, D R Chung, K R Peck, J-H Song.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23011953     DOI： 10.1007/s15010-012-0341-7

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  13 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).

Authors:  Lalitagauri M Deshpande; Ronald N Jones; Thomas R Fritsche; Helio S Sader
Journal:  Int J Antimicrob Agents       Date:  2006-11-16       Impact factor: 5.283

Review 3.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

Review 4.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

5.  High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea.

Authors:  Jung Sik Yoo; Jeonghum Byeon; Jiwoo Yang; Jae Il Yoo; Gyung Tae Chung; Yeong Seon Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2010-05-11       Impact factor: 2.803

6.  Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases.

Authors:  U-I Wu; J-L Wang; W-C Chen; S-C Chang; Y-C Chen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-17       Impact factor: 3.267

7.  Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.

Authors:  Kyungwon Lee; Miae Lee; Jong Hee Shin; Myung Hee Lee; Sung Ha Kang; Ae Ja Park; Dongeun Yong; Yunsop Chong
Journal:  Microb Drug Resist       Date:  2006       Impact factor: 3.431

8.  Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units.

Authors:  Patricia J Baudry; Kim Nichol; Melanie DeCorby; Laura Mataseje; Michael R Mulvey; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

9.  The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.

Authors:  H Ding; Y Yang; Q Lu; Y Wang; Y Chen; L Deng; A Wang; Q Deng; H Zhang; C Wang; L Liu; X Xu; L Wang; X Shen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-01       Impact factor: 3.267

10.  Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.

Authors:  Kwan Soo Ko; Mi Young Lee; Jae-Hoon Song; Hyuck Lee; Dong Sik Jung; Sook-In Jung; Shin-Woo Kim; Hyun-Ha Chang; Joon-Sup Yeom; Yeon-Sook Kim; Hyun Kyun Ki; Doo-Ryeon Chung; Ki Tae Kwon; Kyong Ran Peck; Nam Yong Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2008-05-14       Impact factor: 2.803
View more
  3 in total

Review 1.  Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.

Authors:  Mercedes Delgado-Valverde; Jesús Sojo-Dorado; Alvaro Pascual; Jesús Rodríguez-Baño
Journal:  Ther Adv Infect Dis       Date:  2013-04

2.  Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.

Authors:  Anna Conen; Reno Frei; Hildegard Adler; Marc Dangel; Christoph A Fux; Andreas F Widmer
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

3.  Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea.

Authors:  Hae Suk Cheong; Doo Ryeon Chung; Chaeyoeng Lee; So Hyun Kim; Cheol-In Kang; Kyong Ran Peck; Jae-Hoon Song
Journal:  Antimicrob Resist Infect Control       Date:  2016-11-28       Impact factor: 4.887
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.